» Articles » PMID: 18415132

The Effect of Electroporation Pulses on Functioning of the Heart

Overview
Publisher Springer
Date 2008 Apr 17
PMID 18415132
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Electrochemotherapy is an effective antitumor treatment currently applied to cutaneous and subcutaneous tumors. Electrochemotherapy of tumors located close to the heart could lead to adverse effects, especially if electroporation pulses were delivered within the vulnerable period of the heart or if they coincided with arrhythmias of some types. We examined the influence of electroporation pulses on functioning of the heart of human patients by analyzing the electrocardiogram. We found no pathological morphological changes in the electrocardiogram; however, we demonstrated a transient RR interval decrease after application of electroporation pulses. Although no adverse effects due to electroporation have been reported so far, the probability for complications could increase in treatment of internal tumors, in tumor ablation by irreversible electroporation, and when using pulses of longer durations. We evaluated the performance of our algorithm for synchronization of electroporation pulse delivery with electrocardiogram. The application of this algorithm in clinical electroporation would increase the level of safety for the patient and suitability of electroporation for use in anatomical locations presently not accessible to existing electroporation devices and electrodes.

Citing Articles

Reversible electroporation for cancer therapy.

Shiwani T, Singh Dhesi S, Dhesi S, Wah T Br J Radiol. 2024; 98(1167):313-320.

PMID: 39579146 PMC: 11840168. DOI: 10.1093/bjr/tqae231.


The equivalence of different types of electric pulses for electrochemotherapy with cisplatin - an study.

Scuderi M, Dermol-Cerne J, Scancar J, Markovic S, Rems L, Miklavcic D Radiol Oncol. 2024; 58(1):51-66.

PMID: 38378034 PMC: 10878774. DOI: 10.2478/raon-2024-0005.


Histological Response to 5 kHz Irreversible Electroporation in a Porcine Liver Model.

Kim H, Baik K, Sung C Technol Cancer Res Treat. 2023; 22:15330338231171767.

PMID: 37125478 PMC: 10134162. DOI: 10.1177/15330338231171767.


Toward a Quasi-dynamic Pulsed Field Electroporation Numerical Model for Cardiac Ablation: Predicting Tissue Conductance Changes and Ablation Lesion Patterns.

Simon R, Mehta N, Shah K, Haines D, Linte C Comput Cardiol (2010). 2023; 2022.

PMID: 37124718 PMC: 10134894. DOI: 10.22489/CinC.2022.233.


Potential Application of Pulsed Field Ablation in Ventricular Arrhythmias.

Qiu J, Dai M, Bai Y, Chen G Medicina (Kaunas). 2023; 59(4).

PMID: 37109681 PMC: 10143478. DOI: 10.3390/medicina59040723.


References
1.
Mali B, Jarm T, Jager F, Miklavcic D . An algorithm for synchronization of in vivo electroporation with ECG. J Med Eng Technol. 2005; 29(6):288-96. DOI: 10.1080/03091900512331332591. View

2.
Camacho M, Lehr J, Eisenberg S . A three-dimensional finite element model of human transthoracic defibrillation: paddle placement and size. IEEE Trans Biomed Eng. 1995; 42(6):572-8. DOI: 10.1109/10.387196. View

3.
Sel D, Lebar A, Miklavcic D . Feasibility of employing model-based optimization of pulse amplitude and electrode distance for effective tumor electropermeabilization. IEEE Trans Biomed Eng. 2007; 54(5):773-81. DOI: 10.1109/TBME.2006.889196. View

4.
Niu G, Heller R, Coppola D, Jaroszeski M, Dalton W, Jove R . Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo. Cancer Res. 1999; 59(20):5059-63. View

5.
. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J. 1996; 17(3):354-81. View